| PERIOD ENDING | 27-Nov-09 | 28-Aug-09 | 29-May-09 | 28-Feb-09 | | Total Revenue | 440,166 | 356,350 | 412,922 | 422,519 | | Cost of Revenue | 204,997 | 153,248 | 167,169 | 223,288 | | | Gross Profit | 235,169 | 203,102 | 245,753 | 199,231 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 219,201 | 138,241 | 223,141 | 210,900 | | Non Recurring | (26,376) | 26,376 |
-
| 45,881 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,344 | 38,485 | 22,612 | (57,550) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,126 | 2,280 | 1,318 | (4,436) | | Earnings Before Interest And Taxes | 44,470 | 40,765 | 23,930 | (61,986) | | Interest Expense | 6,331 | 6,671 | 6,987 | 5,881 | | Income Before Tax | 38,139 | 34,094 | 16,943 | (67,867) | | Income Tax Expense | 8,444 | 10,972 | 6,982 | (17,789) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,695 | 23,122 | 9,961 | (50,078) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,695 | 23,122 | 9,961 | (50,078) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,695 | $23,122 | $9,961 | ($50,078) |
|
1.52% Nasdaq 
Income Statement
